- Home
- STRO vs GLDG Comparison
STRO vs GLDG Comparison
Compare STRO & GLDG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STRO
- GLDG
- Stock Information
- Founded
- STRO 2003
- GLDG 2009
- Country
- STRO United States
- GLDG Canada
- Employees
- STRO 306
- GLDG N/A
- Industry
- STRO Biotechnology: Biological Products (No Diagnostic Substances)
- GLDG Precious Metals
- Sector
- STRO Health Care
- GLDG Basic Materials
- Exchange
- STRO Nasdaq
- GLDG Nasdaq
- Market Cap
- STRO 165.7M
- GLDG 155.3M
- IPO Year
- STRO 2018
- GLDG N/A
- Fundamental
- Price
- STRO $2.01
- GLDG $0.79
- Analyst Decision
- STRO Strong Buy
- GLDG Strong Buy
- Analyst Count
- STRO 7
- GLDG 1
- Target Price
- STRO $12.14
- GLDG $5.50
- AVG Volume (30 Days)
- STRO 984.3K
- GLDG 448.0K
- Earning Date
- STRO 11-13-2024
- GLDG 02-25-2025
- Dividend Yield
- STRO N/A
- GLDG N/A
- EPS Growth
- STRO N/A
- GLDG N/A
- EPS
- STRO N/A
- GLDG N/A
- Revenue
- STRO $160,955,000.00
- GLDG N/A
- Revenue This Year
- STRO N/A
- GLDG N/A
- Revenue Next Year
- STRO N/A
- GLDG N/A
- P/E Ratio
- STRO N/A
- GLDG N/A
- Revenue Growth
- STRO 230.90
- GLDG N/A
- 52 Week Low
- STRO $1.67
- GLDG $0.75
- 52 Week High
- STRO $6.13
- GLDG $1.06
- Technical
- Relative Strength Index (RSI)
- STRO 46.47
- GLDG 44.55
- Support Level
- STRO $1.72
- GLDG $0.79
- Resistance Level
- STRO $2.15
- GLDG $0.81
- Average True Range (ATR)
- STRO 0.14
- GLDG 0.03
- MACD
- STRO 0.05
- GLDG 0.00
- Stochastic Oscillator
- STRO 70.83
- GLDG 35.57
About STRO Sutro Biopharma Inc.
Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers.
About GLDG GoldMining Inc.
GoldMining Inc is a mineral exploration company with a focus on the acquisition, exploration, and development of projects in Colombia, Brazil, the United States, Canada, and Peru. The principal projects are its La Mina Gold project and its Titiribi Gold-Copper project, located in Colombia, Crucero project, located in Peru, Sao Jorge, Batistao, Boa Vista, located in Brazil, Yellowknife Gold Project, located in the Northwest Territories, Canada, and other projects. The company earns maximum revenue from Canada.